Press Release
Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer
NEW YORK and PARIS, September 9th, 2025 (GLOBE NEWSWIRE) – Rarecells, a pioneer in liquid biopsy technologies, today presented new data (poster EP.06.64) at the
September 9, 2025
No Comments
